Diazoflex-MR Gel

Introduction

Diazoflex-MR is a topical medication that contains a combination of active ingredients, including Diclofenac, Linseed Oil, Menthol, Methyl Salicylate, and Thiocolchicoside. It is available in gel form and is primarily used for the relief of pain and inflammation associated with musculoskeletal conditions.

Uses

Diazoflex-MR is commonly prescribed for the treatment of various musculoskeletal conditions, including sprains, strains, muscle aches, and joint pain. It can also be used to alleviate pain and inflammation caused by arthritis and other inflammatory conditions.

Dosage and Administration

Before applying Diazoflex-MR, clean and dry the affected area. A thin layer of the gel should be gently massaged into the skin over the affected area. The gel can be applied 3 to 4 times daily, or as directed by your healthcare provider. Follow the dosage instructions provided by your healthcare professional.

Mechanism of Action

Diazoflex-MR works by reducing pain and inflammation in the affected area. Diclofenac belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain chemicals in the body that cause pain and inflammation. Linseed Oil, Menthol, Methyl Salicylate, and Thiocolchicoside provide additional analgesic and anti-inflammatory effects, helping to alleviate pain and swelling.

Side Effects

Common side effects may include skin irritation, redness, or rash at the application site. These side effects are usually mild and temporary. However, if you experience severe skin reactions, such as blistering or peeling, or if you have difficulty breathing or swallowing, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. Diazoflex-MR may interact with certain medications, such as blood thinners or other NSAIDs, which could increase the risk of bleeding. Discuss potential drug interactions with your healthcare provider before using Diazoflex-MR.

Precautions

Before using Diazoflex-MR, inform your healthcare provider if you have any allergies to the active ingredients or any other medications. Disclose any medical conditions you have, especially if you have a history of stomach ulcers, bleeding disorders, or liver or kidney problems. Diazoflex-MR should not be applied to broken or infected skin. Avoid contact with eyes, mouth, and other mucous membranes.

Storage

Diazoflex-MR should be stored at room temperature, away from direct sunlight and heat sources. Keep the gel out of reach of children and pets. Do not freeze the gel or use it if it has expired.

Patient Tips

• Wash your hands before and after applying Diazoflex-MR.
• Avoid applying the gel to open wounds, cuts, or damaged skin.
• Do not cover the treated area with a bandage or tight clothing unless directed by your healthcare provider.
• If you accidentally swallow the gel, seek medical attention immediately.
• If your symptoms do not improve or worsen after using Diazoflex-MR, consult your healthcare provider.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Diclofenac: a non-steroidal anti-inflammatory drug (NSAID) for pain and swelling (NHS UK) [Accessed 0 Jun. 2024] (online) Available at:
• Diclofenac 2.32% gel (Health Professionals SmPC) Available at:
• Diclofenac (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• aleve (diclofenac) 1 % topical gel non-steroidal anti-inflammatory agents (nsaid) (OTC) [Accessed 20 Jun. 2024] (online) Available at:
• Diclofenac Topical (arthritis pain) [Accessed 5 Jun. 2024] (online) Available at:
• Hamed R, Mahmoud NN, Alnadi SH, Alkilani AZ, Hussein G. Diclofenac diethylamine nanosystems-loaded bigels for topical delivery: development, rheological characterization, and release studies. Drug Dev Ind Pharm. 2020 Oct;46(10):1705-1715. doi: 10.1080/03639045.2020.1820038. Epub 2020 Sep 18. [Accessed 23 Jun. 2024] Available at: